跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Privigen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Privigen
Approved
STANDARD
Privigen
CSL Behring AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b6e96b7552a5935c
Company
CSL Behring AG
Type
Standard
Approval Details
Approval Id
b6e96b7552a5935c
Drug Approval Philippines Name
Privigen
Product Name
Privigen
Registration Number
BR-1244
Brand Name
Privigen
Generic Name
Human Normal Immunoglobulin
Dosage Form
Solution for Infusion (IV)
Dosage Strength
100 mg/mL (10% w/v)
Manufacturer
CSL Behring AG
Importer
Zuellig Pharma Corporation
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/csl-behring-ag
Issuance Date
28 June 2022
Expiry Date
05 October 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b6e96b7552a5935c
Type
Standard
Back to Philippines FDA Approvals